| 000 | 02932nam a22006015i 4500 | ||
|---|---|---|---|
| 999 |
_c200458321 _d76533 |
||
| 003 | TR-AnTOB | ||
| 005 | 20231109085907.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 220426s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783030953348 | ||
| 024 | 7 |
_a10.1007/978-3-030-95334-8 _2doi |
|
| 040 |
_aTR-AnTOB _beng _erda _cTR-AnTOB |
||
| 060 | _aWL 344 | ||
| 072 | 7 |
_aMJ _2bicssc |
|
| 072 | 7 |
_aMED045000 _2bisacsh |
|
| 072 | 7 |
_aMJ _2thema |
|
| 096 | _aWL344EBK | ||
| 245 | 1 | 0 |
_aNovel Synthetic Drugs in Migraine _h[electronic resource] / _cedited by Paolo Martelletti, Lars Edvinsson. |
| 250 | _a1st ed. 2022. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aHeadache, _x2197-6538 |
|
| 520 | _aPublished in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant). These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development. | ||
| 650 | 0 | _aInternal medicine. | |
| 650 | 0 | _aNeurology . | |
| 650 | 0 | _aEmergency medicine. | |
| 650 | 0 | _aPain medicine. | |
| 650 | 0 | _aPharmacology. | |
| 650 | 1 | 4 | _aInternal Medicine. |
| 650 | 2 | 4 | _aNeurology. |
| 650 | 2 | 4 | _aEmergency Medicine. |
| 650 | 2 | 4 | _aPain Medicine. |
| 650 | 2 | 4 | _aPharmacology. |
| 653 | 0 | _aMigraine Disorders -- drug therapy | |
| 653 | 0 | _aMigraine Disorders -- prevention & control | |
| 653 | 0 | _aTreatment Outcome | |
| 653 | 0 | _aControlled Clinical Trials as Topic | |
| 700 | 1 |
_aMartelletti, Paolo. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aEdvinsson, Lars. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 830 | 0 |
_aHeadache, _x2197-6538 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-030-95334-8 _3Springer eBooks _zOnline access link to the resource |
| 942 |
_2NLM _cEBK |
||
| 041 | _aeng | ||